Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A in Mixed Dyslipidemia Patients

NCT05809687 is registered in ClinicalTrials.gov with Dongkwang Pharm. Co., Ltd. as lead sponsor.

NCT NCT05809687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05809687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A in Mixed Dyslipidemia Patients
Lead sponsor
Dongkwang Pharm. Co., Ltd.
Phase
Phase 3
Overall status
Withdrawn
Start date
January 1, 2025
Completion date
December 1, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias